• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)

$500.00 – $2,400.00

Clear
SKU: KLI2651343 Categories: Pharmaceuticals Market Research, Vaccines Market Reports Pages: 60
  • Description
  • Table of Contents
  • Latest reports

Description

The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths.

Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and high publicity vaccine products? Kalorama has looked at vaccine products over the past decade and has seen the rise of interest in these products among pharmaceutical companies. While many suggest the H1N1 was a one time event, Kalorama believes there is something important to be gained in a market review of 2009 flu vaccine sales that will inform executives, investors and market watchers who are interested in the vaccine market.

This Kalorama Information report takes a detailed look at the H1N1 vaccine sales of 2009 based on available annual reports. Companies covered include AstraZeneca, Novartis, Glaxo and CSL among others. As part of its coverage, the report includes:

  • 2009 H1N1 Vaccine Sales Results
  • Stockpiles, Returns, Delivery Systems and other Issues and Trends in Vaccine Sales
  • H1N1 Etiology and Statistics
  • Forecasts for 2010-2013 Influenza Vaccine Market
  • Trending in Government Contracts
  • Seasonal and H1N1 Flu Market Interplay
  • Conclusions for Future Pandemic Vaccine Sales
  • Market Share of Major Companies
  • Company Profiles

As part of its coverage, the following vaccine makers are profiled

  • Baxter Healthcare
  • GlaxoSmithKline
  • CSL
  • Medimmune (Astra Zeneca)
  • Merck & Co. Inc
  • Novartis
  • Sanofi Pasteur
  • Sinovac
  • Hualan Biological Engineering Co.
  • Novovax

This Kalorama Information report was created as the result of both secondary and primary research. Research was conducted into the annual reports of major vaccine concerns, trade media coverage, company websites and medical and government literature. Interviews were used to make forecasts on the vaccine market and the influenza vaccine market for 2010-2014, which have been utilized in our estimate of the swine flu vaccine market impact for the 2010-2014 years. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Vaccine Products
  • Sales Results
  • Forecasts
  • Scope and Methodology

CHAPTER TWO: INTRODUCTION

  • Vaccination For Swine Flu
  • Trends Driving Vaccines
  • H1N1 added to new Immunization Schedules
  • Swine Flu Vaccine Manufacturing Process
  • Novartis
  • CSL
  • Baxter Vaccines

CHAPTER THREE: MARKET TRENDS IMPACTING SWINE FLU VACCINE

  • H1n1 Vaccine Returns and Redirects
  • Vaccination Resistance
  • DTC Advertising And Retail Clinics
  • H1n1 Statiscs Compared to Seasonal Flu
  • Other Vaccine Revenue Earners (Stores, Doctors, Insurance Companies)
  • Showcase for Intranasal Delivery
  • Vaccine Supply Issues
  • Next Pandemic’ Strategy

CHAPTER FOUR: MARKET ANALYSIS

  • Products on the Market
  • Key Drivers
  • Analysis of 2009 Sales Results
  • Analysis of 2009 Sales Results
  • Market By Region
  • Market By Delivery System
  • Conclusions
  • Market Forecasts
    • Gardasil as a Model
    • Gardasil/Cervarix Sales, 2006-2010(E)
    • Quadravalent Vaccine
    • H1N1 & Influenza Vaccine Market Forecast

CHAPTER FIVE: COMPANY PROFILES

  • Baxter Healthcare
  • GlaxoSmithKline
  • CSL
  • Medimmune (Astra Zeneca)
  • Merck & Co. Inc
  • Novartis
  • Sanofi Pasteur
  • Sinovac
  • Hualan Biological Engineering Co.
  • Novovax.

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: US& Worldwide A/H1N1 Cases
  • Table 1-2: H1N1 Vaccine Products on the Market
  • Table 1-3: Swine Flu Vaccine Sales, 2009

CHAPTER TWO: INTRODUCTION

  • Table 2-2: Previous Flu Outbreaks
  • Table 2-2: WHO GAR Update on Swine Flu March 2010
  • Table 2-3: US& Worldwide A/H1N1 Cases
  • Table 2-4: Deaths from A/H1N1
  • Figure 2-1: Sales Growth of Vaccines vs. Pharmaceuticals 2004-2013

CHAPTER FOUR: MARKET ANALYSIS

  • Table 4-1: Selected Government Orders for Swine Flu Vaccine
  • Figure 4-1: Doses Ordered as a Percentage of Population, Select Countries (United States, UK, Netherlands, Brazil, Croatia, France)
  • Table 4-2: Swine Flu Vaccine Sales, 2009
  • Figure 4-2: Estimated Regional Swine Flu Sales, 2009 (NA, EU, ASIA, ROW)
  • Figure 4-3: Delivery System Used (Injectible, Intranasal)
  • Table 4-4: World Cervical CancerVaccine Market (Gardasil and Cervarix) 2004-2010
  • Table 4-5: Market Forecast: H1N1 Vaccine sales
  • Table 4-6: Market Forecast: Influenza Vaccine with H1N1 impact
  • Figure 4-5: Market Forecast: Influenza Vaccine with H1N1 Impact

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Men’s Health: The World Market for Current and Emerging Drug Therapies

    $2,625.00 – $5,250.00
  • Placeholder image

    Drug Delivery Technology and Applications: A summary of Kalorama’s market research, 2001-2003

    $746.00 – $1,492.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for Prescription Dermatological Drugs, 7th EditionThe Worldwide Over-the-Counter (OTC) Drug Market
Scroll to top